Detalles de la búsqueda
1.
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study.
Future Oncol
; 19(23): 1601-1611, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37577810
2.
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001711
3.
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy.
JCO Precis Oncol
; 7: e2300255, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797285
4.
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials.
Eur J Cancer
; 189: 112910, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301718
5.
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target.
Am Soc Clin Oncol Educ Book
; 42: 1-14, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580290
6.
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Cancer Treat Rev
; 103: 102326, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35016085
7.
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO.
Clin Colorectal Cancer
; 21(3): 220-228, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304089
8.
The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer.
Eur J Cancer
; 177: 112-119, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335781
9.
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies.
Eur J Cancer
; 167: 23-31, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35366570
10.
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Nat Med
; 28(8): 1612-1618, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35915157
11.
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients.
Front Oncol
; 12: 989713, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36313660
12.
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study.
Cancers (Basel)
; 13(20)2021 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34680277
13.
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
J Immunother Cancer
; 9(4)2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849927
14.
Ramucirumab: the long and winding road toward being an option for mCRC treatment.
Expert Opin Biol Ther
; 19(5): 399-409, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917706
Resultados
1 -
14
de 14
1
Próxima >
>>